Format

Send to

Choose Destination
J Community Health. 2018 Feb;43(1):128-136. doi: 10.1007/s10900-017-0395-7.

Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.

Author information

1
The Center for Health Research, Kaiser Permanente Northwest, 3800 North Interstate Avenue, Portland, OR, 97227, USA. Amanda.f.petrik@kpchr.org.
2
OCHIN, 1881 SW Naito Pkwy, Portland, OR, 97201, USA.
3
The Center for Health Research, Kaiser Permanente Northwest, 3800 North Interstate Avenue, Portland, OR, 97227, USA.
4
PacificSource Community Solutions, 2965 North East Connors Avenue, Bend, OR, 97701, USA.
5
Kaiser Permanente Washington, Research Institute, 1730 Minor Ave #1600, Seattle, WA, 98101, USA.

Abstract

Colorectal cancer screening can prevent cancer deaths. Federally qualified health centers serve a unique patient population that often is not screened. Knowing who in this environment is getting screened via fecal testing and via colonoscopy can assist in tailoring intervention to raise rates of colorectal cancer screening. We examined patient-level and neighborhood-level characteristics associated with being up to date with colorectal cancer screening guidelines. We also examined associations between these factors and being screened with a fecal test. We observed an increase in colorectal cancer screening rates from 2010 to 2015. Adjusted analyses revealed that the following factors were significantly associated with colorectal cancer screening: aged 65 or older, having any type of insurance, previous outpatient visits, and current or other preventive screenings. Among adults aged 50-75 who were up to date with colorectal cancer screening, factors associated with use of fecal testing, as opposed to colonoscopy, were: being younger, speaking a non-English language, being uninsured, having prior office visits, and having had a flu shot in past year. Our findings may inform clinic-based effort to raise rates of colorectal cancer screening, especially in the community clinic setting.

TRIAL REGISTRATION:

ClinicalTrials.gov , NCT01742065.

KEYWORDS:

Colonoscopy; Colorectal cancer screening; Community health; Fecal testing

PMID:
28744716
PMCID:
PMC5767531
[Available on 2019-02-01]
DOI:
10.1007/s10900-017-0395-7

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center